Status:

RECRUITING

Effect of Additional Treatment With NMES After Achilles Tendon Rupture

Lead Sponsor:

Vastra Gotaland Region

Collaborating Sponsors:

Göteborg University

Conditions:

Achilles Tendon Rupture

Physical Disability

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Increased knowledge is needed about new methods how to treat patients with Achilles tendon ruptures (ATR). A goal is to be able to individualize as well as improve treatment beyond the question about ...

Detailed Description

BACKGROUND: There is limited knowledge about how calf muscle performance and tendon elongation affect the patient's discomfort or ability to return to previous activity levels after an Achilles Tendo...

Eligibility Criteria

Inclusion

  • Achilles Tendon rupture
  • The injury should have been treated within two days from the trauma
  • The rupture is located in the mid portion of the tendon

Exclusion

  • Pregnancy
  • Having a pace maker, intra cardiac defibrillator or other active implant
  • Having had an Achilles Tendon rupture before, regardless of side
  • Having an earlier injury that will have an impact on lower leg function, regardless of side
  • Diabetes
  • Neuro vascular disease
  • Immunosuppressive treatment
  • Difficulties to understand the language or difficulties in understand instructions.
  • Unable to consent

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06009978

Start Date

November 1 2023

End Date

December 1 2026

Last Update

November 14 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Forskningsenhet Ortopedi, Sahlgrenska universitetssjukhuset, Mölndal

Mölndal, VGregion, Sweden, 43180